Earnings

Novo Nordisk raises 2026 outlook as oral Wegovy drives GLP-1 market expansion

The global branded obesity-medication market grew volumes by roughly 70% from the second quarter of 2025, a demand environment that carried Novo Nordisk A/S through a margin-pressured quarter and into an upgraded full-year…

By Harlan Prescott·August 9, 2026·二〇二六年八月九日·3 min read

Source · 來源

finance.yahoo.com

Share · 分享

X in f w

← Back to the News Desk Filed · Earnings

Related Dispatches

相關報導

News Desk →

01Earnings
Giants Face Rams in Monday Night Football as Betting Lines Shift
The NFL season has entered a phase where preseason narratives collide with early-game reality, and the betting market is…
September 22, 2026 · 2 min
02Earnings
MIT Overtakes Princeton As Top U.S. College In News Rankings
The hierarchy of American higher education has shifted, ending Princeton's fifteen-year hold on the top spot in the U.S. News…
September 22, 2026 · 2 min
03Earnings
Tax-loss selling sets up potential January rebound for beaten-down equities
The fourth quarter often brings a specific type of mechanical selling that distorts price discovery, setting the stage for a…
September 21, 2026 · 2 min

Elsewhere on the Desk

All Dispatches →

Macro

Nissan Expands US Capacity with 2027 Rogue Hybrid Debut

September 22, 2026 · 2 min

Markets市場

NSE IPO Draws Over $10 Billion in Bids Amid Global Rate Pressures

September 22, 2026 · 2 min

Macro

US Oil Futures Climb Above $96 on US-Iran Negotiation Prospects

September 22, 2026 · 2 min

Crypto加密

Rep Burlison warns $40T debt forces painful fiscal reckoning

September 22, 2026 · 2 min